| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | type I interferon receptor binding | 1.58e-12 | 17 | 104 | 7 | GO:0005132 | |
| GeneOntologyMolecularFunction | G protein-coupled photoreceptor activity | 9.07e-07 | 15 | 104 | 4 | GO:0008020 | |
| GeneOntologyMolecularFunction | photoreceptor activity | 1.57e-06 | 17 | 104 | 4 | GO:0009881 | |
| GeneOntologyMolecularFunction | cytokine activity | 4.94e-05 | 250 | 104 | 8 | GO:0005125 | |
| GeneOntologyMolecularFunction | oxysterol binding | 7.32e-05 | 16 | 104 | 3 | GO:0008142 | |
| GeneOntologyMolecularFunction | transforming growth factor beta receptor activity, type I | 2.66e-04 | 5 | 104 | 2 | GO:0005025 | |
| GeneOntologyMolecularFunction | cytokine receptor binding | 2.94e-04 | 324 | 104 | 8 | GO:0005126 | |
| GeneOntologyMolecularFunction | inward rectifier potassium channel activity | 4.09e-04 | 28 | 104 | 3 | GO:0005242 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein serine/threonine kinase activity | 5.03e-04 | 30 | 104 | 3 | GO:0004693 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein kinase activity | 5.03e-04 | 30 | 104 | 3 | GO:0097472 | |
| GeneOntologyMolecularFunction | sterol binding | 5.16e-04 | 71 | 104 | 4 | GO:0032934 | |
| GeneOntologyMolecularFunction | 1-alkyl-2-acetylglycerophosphocholine esterase activity | 7.37e-04 | 8 | 104 | 2 | GO:0003847 | |
| GeneOntologyMolecularFunction | cyclin binding | 7.96e-04 | 35 | 104 | 3 | GO:0030332 | |
| GeneOntologyMolecularFunction | calcium-independent phospholipase A2 activity | 9.44e-04 | 9 | 104 | 2 | GO:0047499 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | SAMD8 POLG AAK1 TGFBR1 BMPR1A SELENOO MAPK7 BRSK1 KIT PIGO CDK2 CDK4 CDK6 | 1.17e-03 | 938 | 104 | 13 | GO:0016772 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 1.18e-03 | 40 | 104 | 3 | GO:0016709 | |
| GeneOntologyMolecularFunction | NAD(P)H oxidase H2O2-forming activity | 1.71e-03 | 12 | 104 | 2 | GO:0016174 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-serine phosphorylation of STAT protein | 7.41e-12 | 21 | 104 | 7 | GO:0033141 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-serine phosphorylation of STAT protein | 2.18e-11 | 24 | 104 | 7 | GO:0033139 | |
| GeneOntologyBiologicalProcess | serine phosphorylation of STAT protein | 7.33e-11 | 28 | 104 | 7 | GO:0042501 | |
| GeneOntologyBiologicalProcess | natural killer cell activation involved in immune response | 1.58e-09 | 42 | 104 | 7 | GO:0002323 | |
| GeneOntologyBiologicalProcess | response to exogenous dsRNA | 1.12e-08 | 55 | 104 | 7 | GO:0043330 | |
| GeneOntologyBiologicalProcess | response to dsRNA | 2.96e-08 | 63 | 104 | 7 | GO:0043331 | |
| GeneOntologyBiologicalProcess | B cell proliferation | 2.16e-07 | 124 | 104 | 8 | GO:0042100 | |
| GeneOntologyBiologicalProcess | regulation of receptor signaling pathway via JAK-STAT | 2.30e-07 | 125 | 104 | 8 | GO:0046425 | |
| GeneOntologyBiologicalProcess | type I interferon-mediated signaling pathway | 2.42e-07 | 85 | 104 | 7 | GO:0060337 | |
| GeneOntologyBiologicalProcess | cellular response to type I interferon | 2.62e-07 | 86 | 104 | 7 | GO:0071357 | |
| GeneOntologyBiologicalProcess | cellular response to virus | 3.58e-07 | 90 | 104 | 7 | GO:0098586 | |
| GeneOntologyBiologicalProcess | response to type I interferon | 4.16e-07 | 92 | 104 | 7 | GO:0034340 | |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | IFNA2 IFNA5 IFNA6 IFNA7 IFNA8 IFNA16 IFNA21 TGFBR1 MAPK7 BRSK1 CDK2 | 4.34e-07 | 307 | 104 | 11 | GO:0018105 |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | IFNA2 IFNA5 IFNA6 IFNA7 IFNA8 IFNA16 IFNA21 TGFBR1 MAPK7 BRSK1 CDK2 | 6.33e-07 | 319 | 104 | 11 | GO:0018209 |
| GeneOntologyBiologicalProcess | regulation of receptor signaling pathway via STAT | 6.45e-07 | 143 | 104 | 8 | GO:1904892 | |
| GeneOntologyBiologicalProcess | regulation of defense response to virus by host | 7.65e-07 | 63 | 104 | 6 | GO:0050691 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-serine phosphorylation | 7.88e-07 | 101 | 104 | 7 | GO:0033138 | |
| GeneOntologyBiologicalProcess | B cell differentiation | 8.19e-07 | 201 | 104 | 9 | GO:0030183 | |
| GeneOntologyBiologicalProcess | T cell activation involved in immune response | 8.37e-07 | 148 | 104 | 8 | GO:0002286 | |
| GeneOntologyBiologicalProcess | interferon-mediated signaling pathway | 1.59e-06 | 112 | 104 | 7 | GO:0140888 | |
| GeneOntologyBiologicalProcess | natural killer cell activation | 3.14e-06 | 124 | 104 | 7 | GO:0030101 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | SH3RF1 CYP27B1 IFNA2 IFNA5 IFNA6 IFNA7 IFNA8 IFNA16 IFNA21 TGFBR1 P2RY1 UCP1 INSIG2 SMO CDK2 CDK4 DNMT3A CDK6 | 4.63e-06 | 1048 | 104 | 18 | GO:0014070 |
| GeneOntologyBiologicalProcess | regulation of peptidyl-serine phosphorylation | 6.08e-06 | 137 | 104 | 7 | GO:0033135 | |
| GeneOntologyBiologicalProcess | regulation of defense response to virus | 6.28e-06 | 90 | 104 | 6 | GO:0050688 | |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via JAK-STAT | 7.34e-06 | 198 | 104 | 8 | GO:0007259 | |
| GeneOntologyBiologicalProcess | detection of visible light | 1.01e-05 | 57 | 104 | 5 | GO:0009584 | |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via STAT | 1.38e-05 | 216 | 104 | 8 | GO:0097696 | |
| GeneOntologyBiologicalProcess | mesenchyme morphogenesis | 1.92e-05 | 65 | 104 | 5 | GO:0072132 | |
| GeneOntologyBiologicalProcess | sulfur oxidation | 2.52e-05 | 2 | 104 | 2 | GO:0019417 | |
| GeneOntologyBiologicalProcess | detection of external stimulus | 2.77e-05 | 173 | 104 | 7 | GO:0009581 | |
| GeneOntologyBiologicalProcess | detection of abiotic stimulus | 2.99e-05 | 175 | 104 | 7 | GO:0009582 | |
| GeneOntologyBiologicalProcess | paraxial mesoderm morphogenesis | 3.43e-05 | 13 | 104 | 3 | GO:0048340 | |
| GeneOntologyBiologicalProcess | humoral immune response | 3.60e-05 | 321 | 104 | 9 | GO:0006959 | |
| GeneOntologyBiologicalProcess | lymphocyte activation involved in immune response | 4.05e-05 | 251 | 104 | 8 | GO:0002285 | |
| GeneOntologyBiologicalProcess | detection of light stimulus | 4.38e-05 | 77 | 104 | 5 | GO:0009583 | |
| GeneOntologyBiologicalProcess | B cell activation | 5.75e-05 | 341 | 104 | 9 | GO:0042113 | |
| GeneOntologyBiologicalProcess | positive regulation of transforming growth factor beta2 production | 7.53e-05 | 3 | 104 | 2 | GO:0032915 | |
| GeneOntologyBiologicalProcess | lymphocyte differentiation | SH3RF1 GPR183 IFNA2 IFNA5 IFNA6 IFNA7 IFNA8 IFNA16 IFNA21 KIT CDK6 | 8.44e-05 | 537 | 104 | 11 | GO:0030098 |
| GeneOntologyBiologicalProcess | leukocyte proliferation | SH3RF1 GPR183 IFNA2 IFNA5 IFNA6 IFNA7 IFNA8 IFNA16 IFNA21 KIT | 8.46e-05 | 445 | 104 | 10 | GO:0070661 |
| GeneOntologyBiologicalProcess | leukocyte activation involved in immune response | 8.89e-05 | 361 | 104 | 9 | GO:0002366 | |
| GeneOntologyBiologicalProcess | cell activation involved in immune response | 9.66e-05 | 365 | 104 | 9 | GO:0002263 | |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | RANGAP1 DOK7 IFNA2 IFNA5 IFNA6 IFNA7 IFNA8 IFNA16 IFNA21 TGFBR1 SMO MAPK7 BRSK1 KIT CDK2 | 1.11e-04 | 976 | 104 | 15 | GO:0018193 |
| GeneOntologyBiologicalProcess | phototransduction | 1.48e-04 | 53 | 104 | 4 | GO:0007602 | |
| GeneOntologyBiologicalProcess | disaccharide catabolic process | 1.50e-04 | 4 | 104 | 2 | GO:0046352 | |
| GeneOntologyBiologicalProcess | response to alcohol | 1.84e-04 | 312 | 104 | 8 | GO:0097305 | |
| GeneOntologyBiologicalProcess | lymphocyte proliferation | 1.85e-04 | 398 | 104 | 9 | GO:0046651 | |
| GeneOntologyBiologicalProcess | mononuclear cell proliferation | 2.15e-04 | 406 | 104 | 9 | GO:0032943 | |
| GeneOntologyBiologicalProcess | paraxial mesoderm development | 2.33e-04 | 24 | 104 | 3 | GO:0048339 | |
| GeneOntologyBiologicalProcess | regulation of lipid metabolic process | 2.52e-04 | 415 | 104 | 9 | GO:0019216 | |
| GeneOntologyBiologicalProcess | response to lead ion | 2.64e-04 | 25 | 104 | 3 | GO:0010288 | |
| GeneOntologyBiologicalProcess | positive regulation of protein phosphorylation | DOK7 IFNA2 IFNA5 IFNA6 IFNA7 IFNA8 IFNA16 IFNA21 P2RY1 PLA2G6 KIT SPDYE16 | 2.88e-04 | 724 | 104 | 12 | GO:0001934 |
| GeneOntologyBiologicalProcess | positive regulation of protein metabolic process | SH3RF1 DOK7 IFNA2 IFNA5 IFNA6 IFNA7 IFNA8 IFNA16 IFNA21 TBC1D10A P2RY1 PLA2G6 FBXO33 MAPK7 OGA KIT CDK4 SPDYE16 | 3.40e-04 | 1458 | 104 | 18 | GO:0051247 |
| GeneOntologyBiologicalProcess | defense response to virus | 3.41e-04 | 342 | 104 | 8 | GO:0051607 | |
| GeneOntologyBiologicalProcess | mononuclear cell differentiation | SH3RF1 GPR183 IFNA2 IFNA5 IFNA6 IFNA7 IFNA8 IFNA16 IFNA21 KIT CDK6 | 3.85e-04 | 640 | 104 | 11 | GO:1903131 |
| GeneOntologyBiologicalProcess | regulation of protein modification process | MICAL1 IPO7 DOK7 IFNA2 IFNA5 IFNA6 IFNA7 IFNA8 IFNA16 IFNA21 TGFBR1 P2RY1 PLA2G6 SMO FBXO33 OGA KIT SPDYE16 | 4.34e-04 | 1488 | 104 | 18 | GO:0031399 |
| GeneOntologyBiologicalProcess | positive regulation of phosphate metabolic process | DOK7 IFNA2 IFNA5 IFNA6 IFNA7 IFNA8 IFNA16 IFNA21 P2RY1 PLA2G6 PC KIT SPDYE16 | 4.75e-04 | 879 | 104 | 13 | GO:0045937 |
| GeneOntologyBiologicalProcess | positive regulation of phosphorus metabolic process | DOK7 IFNA2 IFNA5 IFNA6 IFNA7 IFNA8 IFNA16 IFNA21 P2RY1 PLA2G6 PC KIT SPDYE16 | 4.75e-04 | 879 | 104 | 13 | GO:0010562 |
| GeneOntologyBiologicalProcess | dentate gyrus development | 5.05e-04 | 31 | 104 | 3 | GO:0021542 | |
| GeneOntologyBiologicalProcess | regulation of protein phosphorylation | MICAL1 IPO7 DOK7 IFNA2 IFNA5 IFNA6 IFNA7 IFNA8 IFNA16 IFNA21 P2RY1 PLA2G6 SMO KIT SPDYE16 | 5.48e-04 | 1133 | 104 | 15 | GO:0001932 |
| GeneOntologyBiologicalProcess | positive regulation of phosphorylation | DOK7 IFNA2 IFNA5 IFNA6 IFNA7 IFNA8 IFNA16 IFNA21 P2RY1 PLA2G6 KIT SPDYE16 | 5.61e-04 | 780 | 104 | 12 | GO:0042327 |
| GeneOntologyBiologicalProcess | cardiac septum development | 5.90e-04 | 134 | 104 | 5 | GO:0003279 | |
| GeneOntologyBiologicalProcess | response to sterol | 6.65e-04 | 34 | 104 | 3 | GO:0036314 | |
| GeneOntologyBiologicalProcess | regulation of transforming growth factor beta2 production | 6.91e-04 | 8 | 104 | 2 | GO:0032909 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta2 production | 6.91e-04 | 8 | 104 | 2 | GO:0032906 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell differentiation | 8.15e-04 | 217 | 104 | 6 | GO:0030856 | |
| GeneOntologyBiologicalProcess | T cell activation | SH3RF1 GPR183 IFNA2 IFNA5 IFNA6 IFNA7 IFNA8 IFNA16 IFNA21 KIT CDK6 | 8.19e-04 | 701 | 104 | 11 | GO:0042110 |
| GeneOntologyBiologicalProcess | positive regulation of protein modification process | DOK7 IFNA2 IFNA5 IFNA6 IFNA7 IFNA8 IFNA16 IFNA21 P2RY1 PLA2G6 FBXO33 KIT SPDYE16 | 8.60e-04 | 937 | 104 | 13 | GO:0031401 |
| GeneOntologyBiologicalProcess | ventricular compact myocardium morphogenesis | 8.86e-04 | 9 | 104 | 2 | GO:0003223 | |
| GeneOntologyBiologicalProcess | platelet activating factor metabolic process | 8.86e-04 | 9 | 104 | 2 | GO:0046469 | |
| GeneOntologyBiologicalProcess | cardiac septum morphogenesis | 1.07e-03 | 89 | 104 | 4 | GO:0060411 | |
| GeneOntologyBiologicalProcess | visual perception | 1.10e-03 | 230 | 104 | 6 | GO:0007601 | |
| GeneOntologyBiologicalProcess | ventricular septum development | 1.16e-03 | 91 | 104 | 4 | GO:0003281 | |
| GeneOntologyBiologicalProcess | sensory perception of light stimulus | 1.18e-03 | 233 | 104 | 6 | GO:0050953 | |
| GeneOntologyBiologicalProcess | heart morphogenesis | 1.21e-03 | 321 | 104 | 7 | GO:0003007 | |
| GeneOntologyBiologicalProcess | regulation of phosphorylation | MICAL1 IPO7 DOK7 IFNA2 IFNA5 IFNA6 IFNA7 IFNA8 IFNA16 IFNA21 P2RY1 PLA2G6 SMO KIT SPDYE16 | 1.22e-03 | 1226 | 104 | 15 | GO:0042325 |
| GeneOntologyBiologicalProcess | somite development | 1.31e-03 | 94 | 104 | 4 | GO:0061053 | |
| GeneOntologyBiologicalProcess | germ cell migration | 1.34e-03 | 11 | 104 | 2 | GO:0008354 | |
| GeneOntologyBiologicalProcess | positive regulation of protein kinase C signaling | 1.34e-03 | 11 | 104 | 2 | GO:0090037 | |
| GeneOntologyBiologicalProcess | response to virus | 1.40e-03 | 425 | 104 | 8 | GO:0009615 | |
| GeneOntologyBiologicalProcess | endocardial cushion morphogenesis | 1.42e-03 | 44 | 104 | 3 | GO:0003203 | |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | 1.49e-03 | 244 | 104 | 6 | GO:0043547 | |
| GeneOntologyBiologicalProcess | regulation of mesenchymal cell proliferation | 1.52e-03 | 45 | 104 | 3 | GO:0010464 | |
| GeneOntologyBiologicalProcess | regulation of lipid biosynthetic process | 1.55e-03 | 246 | 104 | 6 | GO:0046890 | |
| GeneOntologyBiologicalProcess | notochord morphogenesis | 1.61e-03 | 12 | 104 | 2 | GO:0048570 | |
| GeneOntologyBiologicalProcess | disaccharide metabolic process | 1.61e-03 | 12 | 104 | 2 | GO:0005984 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection assembly | 1.62e-03 | 248 | 104 | 6 | GO:0120032 | |
| GeneOntologyCellularComponent | photoreceptor disc membrane | 8.57e-06 | 26 | 106 | 4 | GO:0097381 | |
| Domain | Interferon_alpha/beta/delta | 2.69e-12 | 17 | 105 | 7 | IPR000471 | |
| Domain | Interferon | 2.69e-12 | 17 | 105 | 7 | PF00143 | |
| Domain | IFabd | 2.69e-12 | 17 | 105 | 7 | SM00076 | |
| Domain | INTERFERON_A_B_D | 2.69e-12 | 17 | 105 | 7 | PS00252 | |
| Domain | - | 1.19e-08 | 50 | 105 | 7 | 1.20.1250.10 | |
| Domain | 4_helix_cytokine_core | 1.37e-08 | 51 | 105 | 7 | IPR012351 | |
| Domain | Opsin_red/grn | 1.73e-07 | 3 | 105 | 3 | IPR000378 | |
| Domain | 4_helix_cytokine-like_core | 1.92e-07 | 74 | 105 | 7 | IPR009079 | |
| Domain | OPSIN | 2.01e-05 | 10 | 105 | 3 | PS00238 | |
| Domain | Opsin | 2.76e-05 | 11 | 105 | 3 | IPR001760 | |
| Domain | K_chnl_inward-rec_Kir2.2 | 3.13e-05 | 2 | 105 | 2 | IPR003272 | |
| Domain | K_chnl_inward-rec_Kir_N | 9.36e-05 | 3 | 105 | 2 | IPR013673 | |
| Domain | IRK_N | 9.36e-05 | 3 | 105 | 2 | PF08466 | |
| Domain | FAD-bd | 4.63e-04 | 6 | 105 | 2 | IPR002938 | |
| Domain | FAD_binding_3 | 4.63e-04 | 6 | 105 | 2 | PF01494 | |
| Domain | GS | 6.45e-04 | 7 | 105 | 2 | SM00467 | |
| Domain | GS_dom | 6.45e-04 | 7 | 105 | 2 | IPR003605 | |
| Domain | GS | 6.45e-04 | 7 | 105 | 2 | PS51256 | |
| Domain | TGF_beta_GS | 6.45e-04 | 7 | 105 | 2 | PF08515 | |
| Domain | Ser/Thr_kinase_AS | 9.18e-04 | 357 | 105 | 8 | IPR008271 | |
| Domain | S_TKc | 9.52e-04 | 359 | 105 | 8 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 1.00e-03 | 362 | 105 | 8 | PS00108 | |
| Domain | PROTEIN_KINASE_ATP | 1.13e-03 | 459 | 105 | 9 | PS00107 | |
| Domain | Protein_kinase_ATP_BS | 1.35e-03 | 379 | 105 | 8 | IPR017441 | |
| Domain | Activin_recp | 1.37e-03 | 10 | 105 | 2 | IPR000472 | |
| Domain | Activin_recp | 1.37e-03 | 10 | 105 | 2 | PF01064 | |
| Domain | Pkinase | 1.39e-03 | 381 | 105 | 8 | PF00069 | |
| Domain | MBOAT_fam | 1.67e-03 | 11 | 105 | 2 | IPR004299 | |
| Domain | MBOAT | 1.67e-03 | 11 | 105 | 2 | PF03062 | |
| Domain | Prot_kinase_dom | 1.75e-03 | 489 | 105 | 9 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 1.85e-03 | 493 | 105 | 9 | PS50011 | |
| Domain | TGFB_receptor | 1.99e-03 | 12 | 105 | 2 | IPR000333 | |
| Domain | TBC | 2.64e-03 | 49 | 105 | 3 | SM00164 | |
| Domain | RabGAP-TBC | 3.30e-03 | 53 | 105 | 3 | PF00566 | |
| Domain | Glycoside_hydrolase_SF | 3.30e-03 | 53 | 105 | 3 | IPR017853 | |
| Domain | Kinase-like_dom | 3.48e-03 | 542 | 105 | 9 | IPR011009 | |
| Domain | K_chnl_inward-rec_Kir_cyto | 3.57e-03 | 16 | 105 | 2 | IPR013518 | |
| Domain | IRK | 3.57e-03 | 16 | 105 | 2 | PF01007 | |
| Domain | - | 3.57e-03 | 16 | 105 | 2 | 2.60.40.1400 | |
| Domain | K_chnl_inward-rec_Kir | 3.57e-03 | 16 | 105 | 2 | IPR016449 | |
| Domain | TBC_RABGAP | 3.66e-03 | 55 | 105 | 3 | PS50086 | |
| Domain | Rab-GTPase-TBC_dom | 3.66e-03 | 55 | 105 | 3 | IPR000195 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_TAT_TO_TLR2_4_NFKB_SIGNALING_PATHWAY | 5.36e-12 | 17 | 88 | 7 | M47564 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CGAS_STING_SIGNALING_PATHWAY | 8.72e-12 | 18 | 88 | 7 | M47539 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF7_SIGNALING_PATHWAY | 1.37e-11 | 19 | 88 | 7 | M47450 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_9_IRF7_SIGNALING_PATHWAY | 2.10e-11 | 20 | 88 | 7 | M47617 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_II_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 3.14e-11 | 21 | 88 | 7 | M47909 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_8_9_IRF5_SIGNALING_PATHWAY | 4.58e-11 | 22 | 88 | 7 | M47897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_NFKB_SIGNALING_PATHWAY | 4.58e-11 | 22 | 88 | 7 | M47616 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_IFN_SIGNALING_PATHWAY | 6.55e-11 | 23 | 88 | 7 | M47452 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 6.55e-11 | 23 | 88 | 7 | MM15634 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_IRF7_3_SIGNALING_PATHWAY | 9.20e-11 | 24 | 88 | 7 | M47576 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MDA5_IRF7_3_SIGNALING_PATHWAY | 9.20e-11 | 24 | 88 | 7 | M47782 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 9.20e-11 | 24 | 88 | 7 | M47908 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 1.73e-10 | 26 | 88 | 7 | M982 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | 5.25e-10 | 30 | 88 | 7 | M936 | |
| Pathway | WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY | 6.75e-10 | 31 | 88 | 7 | M39897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IFN_RIPK1_3_SIGNALING_PATHWAY | 6.75e-10 | 31 | 88 | 7 | M47964 | |
| Pathway | BIOCARTA_IFNA_PATHWAY | 1.27e-09 | 19 | 88 | 6 | MM1571 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 1.36e-09 | 34 | 88 | 7 | MM15631 | |
| Pathway | REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES | 1.69e-09 | 35 | 88 | 7 | M48246 | |
| Pathway | KEGG_REGULATION_OF_AUTOPHAGY | 1.69e-09 | 35 | 88 | 7 | M6382 | |
| Pathway | WP_INTERFERONMEDIATED_SIGNALING | 2.56e-09 | 37 | 88 | 7 | M39785 | |
| Pathway | WP_MEASLES_VIRUS_INFECTION | 1.19e-08 | 136 | 88 | 10 | M42547 | |
| Pathway | WP_CYTOSOLIC_DNASENSING_PATHWAY | 1.61e-08 | 73 | 88 | 8 | M39837 | |
| Pathway | BIOCARTA_CYTOKINE_PATHWAY | 1.68e-08 | 28 | 88 | 6 | MM1378 | |
| Pathway | KEGG_AUTOIMMUNE_THYROID_DISEASE | 3.09e-08 | 52 | 88 | 7 | M13103 | |
| Pathway | KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY | 4.61e-08 | 55 | 88 | 7 | M11844 | |
| Pathway | BIOCARTA_INFLAM_PATHWAY | 4.82e-08 | 33 | 88 | 6 | MM1379 | |
| Pathway | WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE | 1.38e-07 | 39 | 88 | 6 | MM15914 | |
| Pathway | PID_CD8_TCR_DOWNSTREAM_PATHWAY | 1.51e-07 | 65 | 88 | 7 | M272 | |
| Pathway | REACTOME_RSV_HOST_INTERACTIONS | 1.66e-07 | 98 | 88 | 8 | M48247 | |
| Pathway | BIOCARTA_IL1R_PATHWAY | 1.88e-07 | 41 | 88 | 6 | MM1493 | |
| Pathway | KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY | 2.79e-07 | 71 | 88 | 7 | M15913 | |
| Pathway | WP_CANCER_PATHWAYS | WNT11 IFNA2 IFNA5 ADCY9 IFNA6 IFNA7 IFNA8 IFNA16 IFNA21 TGFBR1 SMO KIT CDK2 CDK4 CDK6 | 5.00e-07 | 507 | 88 | 15 | M48302 |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 5.35e-07 | 78 | 88 | 7 | M973 | |
| Pathway | REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA | 7.55e-07 | 82 | 88 | 7 | M1002 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY | 7.94e-07 | 120 | 88 | 8 | M48233 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 1.10e-06 | 170 | 88 | 9 | M941 | |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 1.22e-06 | 88 | 88 | 7 | M16004 | |
| Pathway | KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY | 3.31e-06 | 102 | 88 | 7 | M3261 | |
| Pathway | WP_TOLLLIKE_RECEPTOR_SIGNALING | 3.54e-06 | 103 | 88 | 7 | M39434 | |
| Pathway | WP_HEPATITIS_B_INFECTION | 4.48e-06 | 151 | 88 | 8 | M39801 | |
| Pathway | KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION | IFNA2 IFNA5 IFNA6 IFNA7 IFNA8 IFNA16 IFNA21 TGFBR1 BMPR1A KIT | 5.59e-06 | 264 | 88 | 10 | M9809 |
| Pathway | WP_PI3KAKT_SIGNALING | IFNA2 IFNA5 IFNA6 IFNA7 IFNA8 IFNA16 IFNA21 KIT CDK2 CDK4 CDK6 | 8.11e-06 | 339 | 88 | 11 | M39736 |
| Pathway | REACTOME_THE_RETINOID_CYCLE_IN_CONES_DAYLIGHT_VISION | 1.29e-05 | 8 | 88 | 3 | MM14880 | |
| Pathway | REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES | 1.34e-05 | 126 | 88 | 7 | M45009 | |
| Pathway | WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS | 1.41e-05 | 127 | 88 | 7 | M42533 | |
| Pathway | WP_IL2_SIGNALING_PATHWAY | 1.68e-05 | 87 | 88 | 6 | MM15915 | |
| Pathway | KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY | 2.31e-05 | 137 | 88 | 7 | M5669 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 2.43e-05 | 138 | 88 | 7 | MM15635 | |
| Pathway | REACTOME_OPSINS | 2.73e-05 | 10 | 88 | 3 | MM15063 | |
| Pathway | KEGG_JAK_STAT_SIGNALING_PATHWAY | 5.11e-05 | 155 | 88 | 7 | M17411 | |
| Pathway | BIOCARTA_EFP_PATHWAY | 6.43e-05 | 13 | 88 | 3 | MM1537 | |
| Pathway | REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP | 9.87e-05 | 39 | 88 | 4 | MM14900 | |
| Pathway | BIOCARTA_EFP_PATHWAY | 1.24e-04 | 16 | 88 | 3 | M22011 | |
| Pathway | REACTOME_ABERRANT_REGULATION_OF_MITOTIC_G1_S_TRANSITION_IN_CANCER_DUE_TO_RB1_DEFECTS | 1.50e-04 | 17 | 88 | 3 | M38998 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 2.71e-04 | 92 | 88 | 5 | MM14881 | |
| Pathway | REACTOME_SARS_COV_2_HOST_INTERACTIONS | 2.83e-04 | 204 | 88 | 7 | M45011 | |
| Pathway | BIOCARTA_CELLCYCLE_PATHWAY | 3.80e-04 | 23 | 88 | 3 | M17770 | |
| Pathway | REACTOME_DRUG_MEDIATED_INHIBITION_OF_CDK4_CDK6_ACTIVITY | 3.81e-04 | 5 | 88 | 2 | M45016 | |
| Pathway | REACTOME_DRUG_MEDIATED_INHIBITION_OF_CDK4_CDK6_ACTIVITY | 3.81e-04 | 5 | 88 | 2 | MM15696 | |
| Pathway | BIOCARTA_CELLCYCLE_PATHWAY | 4.33e-04 | 24 | 88 | 3 | MM1376 | |
| Pathway | WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION | 5.51e-04 | 26 | 88 | 3 | M48092 | |
| Pathway | BIOCARTA_RACCYCD_PATHWAY | 5.51e-04 | 26 | 88 | 3 | M14512 | |
| Pathway | BIOCARTA_RACCYCD_PATHWAY | 5.51e-04 | 26 | 88 | 3 | MM1423 | |
| Pathway | REACTOME_SARS_COV_2_INFECTION | 5.51e-04 | 299 | 88 | 8 | M41727 | |
| Pathway | REACTOME_PTK6_REGULATES_CELL_CYCLE | 5.69e-04 | 6 | 88 | 2 | M27733 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_VCYCLIN_TO_CELL_CYCLE_G1_S | 5.69e-04 | 6 | 88 | 2 | M47461 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS | 5.69e-04 | 6 | 88 | 2 | MM15659 | |
| Pathway | REACTOME_PTK6_REGULATES_CELL_CYCLE | 5.69e-04 | 6 | 88 | 2 | MM15483 | |
| Pathway | BIOCARTA_G1_PATHWAY | 6.88e-04 | 28 | 88 | 3 | M648 | |
| Pathway | BIOCARTA_G1_PATHWAY | 7.64e-04 | 29 | 88 | 3 | MM1364 | |
| Pathway | REACTOME_THE_RETINOID_CYCLE_IN_CONES_DAYLIGHT_VISION | 7.93e-04 | 7 | 88 | 2 | M27157 | |
| Pathway | WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1 | 9.31e-04 | 31 | 88 | 3 | M39522 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 9.68e-04 | 326 | 88 | 8 | MM15917 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 1.05e-03 | 8 | 88 | 2 | MM14717 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_CELL_CYCLE_G1_S_N00483 | 1.35e-03 | 9 | 88 | 2 | M49010 | |
| Pathway | REACTOME_OPSINS | 1.35e-03 | 9 | 88 | 2 | M6285 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 1.58e-03 | 273 | 88 | 7 | M983 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P16_CELL_CYCLE_G1_S | 1.68e-03 | 10 | 88 | 2 | M47418 | |
| Pathway | REACTOME_DISEASES_OF_MITOTIC_CELL_CYCLE | 1.69e-03 | 38 | 88 | 3 | M39005 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_MYC_TO_CELL_CYCLE_G1_S | 2.04e-03 | 11 | 88 | 2 | M47426 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 2.04e-03 | 11 | 88 | 2 | M1091 | |
| Pathway | WP_ALANINE_AND_ASPARTATE_METABOLISM | 2.44e-03 | 12 | 88 | 2 | M39331 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_MDM2_TO_P21_CELL_CYCLE_G1_S | 2.44e-03 | 12 | 88 | 2 | M47417 | |
| Pathway | BIOCARTA_RB_PATHWAY | 2.44e-03 | 12 | 88 | 2 | MM1466 | |
| Pathway | REACTOME_GABA_B_RECEPTOR_ACTIVATION | 2.59e-03 | 44 | 88 | 3 | MM15709 | |
| Pathway | REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1 | 2.59e-03 | 44 | 88 | 3 | MM15377 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MDM2_P21_CELL_CYCLE_G1_S_N00066 | 2.87e-03 | 13 | 88 | 2 | M47416 | |
| Pathway | SA_REG_CASCADE_OF_CYCLIN_EXPR | 2.87e-03 | 13 | 88 | 2 | M3686 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P15_CELL_CYCLE_G1_S | 2.87e-03 | 13 | 88 | 2 | M49035 | |
| Pathway | REACTOME_RETINOID_CYCLE_DISEASE_EVENTS | 2.87e-03 | 13 | 88 | 2 | M29612 | |
| Pathway | BIOCARTA_RB_PATHWAY | 2.87e-03 | 13 | 88 | 2 | M18159 | |
| Pathway | REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1 | 3.13e-03 | 47 | 88 | 3 | M29724 | |
| Pathway | REACTOME_HEMOSTASIS | MICAL1 ABCC4 IFNA2 IFNA5 IFNA6 IFNA7 IFNA8 IFNA16 IFNA21 P2RY1 CDK2 | 3.26e-03 | 679 | 88 | 11 | M8395 |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 3.52e-03 | 100 | 88 | 4 | M27158 | |
| Pathway | WP_ALANINE_AND_ASPARTATE_METABOLISM | 3.84e-03 | 15 | 88 | 2 | MM15960 | |
| Pathway | BIOCARTA_P53_PATHWAY | 3.84e-03 | 15 | 88 | 2 | MM1451 | |
| Pathway | SA_G1_AND_S_PHASES | 3.84e-03 | 15 | 88 | 2 | M1529 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P300_P21_CELL_CYCLE_G1_S | 3.84e-03 | 15 | 88 | 2 | M47524 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 4.18e-03 | 325 | 88 | 7 | M12868 | |
| Pubmed | 1.79e-15 | 12 | 108 | 7 | 16565497 | ||
| Pubmed | Evolution of the interferon alpha gene family in eutherian mammals. | 1.79e-15 | 12 | 108 | 7 | 17512142 | |
| Pubmed | Repression of the murine interferon alpha 11 gene: identification of negatively acting sequences. | 1.79e-15 | 12 | 108 | 7 | 1886773 | |
| Pubmed | Multiple pathways of interferon-induced gene expression in murine macrophages. | 1.79e-15 | 12 | 108 | 7 | 7684767 | |
| Pubmed | Negative regulation of the alpha interferon-induced antiviral response by the Ras/Raf/MEK pathway. | 1.79e-15 | 12 | 108 | 7 | 16611902 | |
| Pubmed | Interferon-alpha subtype 11 activates NK cells and enables control of retroviral infection. | 1.79e-15 | 12 | 108 | 7 | 22912583 | |
| Pubmed | Structure and expression of a new murine interferon-alpha gene: MuIFN-alpha I9. | 1.79e-15 | 12 | 108 | 7 | 3758677 | |
| Pubmed | 1.79e-15 | 12 | 108 | 7 | 8245849 | ||
| Pubmed | 1.79e-15 | 12 | 108 | 7 | 11846978 | ||
| Pubmed | Identification of distal silencing elements in the murine interferon-A11 gene promoter. | 1.79e-15 | 12 | 108 | 7 | 8760352 | |
| Pubmed | Role of interferons in the regulation of cell proliferation, differentiation, and development. | 1.79e-15 | 12 | 108 | 7 | 7530016 | |
| Pubmed | 1.79e-15 | 12 | 108 | 7 | 9794206 | ||
| Pubmed | 1.79e-15 | 12 | 108 | 7 | 17451966 | ||
| Pubmed | Characterization of interferon-alpha 13, a novel constitutive murine interferon-alpha subtype. | 3.86e-15 | 13 | 108 | 7 | 12930842 | |
| Pubmed | Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. | 3.86e-15 | 13 | 108 | 7 | 2014240 | |
| Pubmed | 3.86e-15 | 13 | 108 | 7 | 18005734 | ||
| Pubmed | 3.86e-15 | 13 | 108 | 7 | 12050368 | ||
| Pubmed | Isolation and bacterial expression of a murine alpha leukocyte interferon gene. | 3.86e-15 | 13 | 108 | 7 | 6094686 | |
| Pubmed | 3.86e-15 | 13 | 108 | 7 | 1655578 | ||
| Pubmed | 3.86e-15 | 13 | 108 | 7 | 2471809 | ||
| Pubmed | 3.86e-15 | 13 | 108 | 7 | 8438572 | ||
| Pubmed | 3.86e-15 | 13 | 108 | 7 | 9343822 | ||
| Pubmed | Evidence for a different susceptibility of primate lentiviruses to type I interferons. | 3.86e-15 | 13 | 108 | 7 | 23255800 | |
| Pubmed | 3.86e-15 | 13 | 108 | 7 | 7523540 | ||
| Pubmed | 3.86e-15 | 13 | 108 | 7 | 19706714 | ||
| Pubmed | Organization, structure and expression of murine interferon alpha genes. | 3.86e-15 | 13 | 108 | 7 | 2987810 | |
| Pubmed | 3.86e-15 | 13 | 108 | 7 | 19130550 | ||
| Pubmed | 3.86e-15 | 13 | 108 | 7 | 22739040 | ||
| Pubmed | 3.86e-15 | 13 | 108 | 7 | 9181467 | ||
| Pubmed | Sequencing and bacterial expression of a novel murine alpha interferon gene. | 3.86e-15 | 13 | 108 | 7 | 18726328 | |
| Pubmed | 3.86e-15 | 13 | 108 | 7 | 18572754 | ||
| Pubmed | Interferon induction by HIV glycoprotein 120: role of the V3 loop. | 7.70e-15 | 14 | 108 | 7 | 7526537 | |
| Pubmed | 7.70e-15 | 14 | 108 | 7 | 19559726 | ||
| Pubmed | 7.70e-15 | 14 | 108 | 7 | 15240719 | ||
| Pubmed | 7.70e-15 | 14 | 108 | 7 | 16418394 | ||
| Pubmed | 7.70e-15 | 14 | 108 | 7 | 18272764 | ||
| Pubmed | 7.70e-15 | 14 | 108 | 7 | 11884139 | ||
| Pubmed | 7.70e-15 | 14 | 108 | 7 | 19004943 | ||
| Pubmed | 7.70e-15 | 14 | 108 | 7 | 2552026 | ||
| Pubmed | Modulation of interferon-mediated inhibition of human immunodeficiency virus type 1 by Tat. | 7.70e-15 | 14 | 108 | 7 | 7532202 | |
| Pubmed | 7.70e-15 | 14 | 108 | 7 | 18200012 | ||
| Pubmed | Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. | 7.70e-15 | 14 | 108 | 7 | 18200009 | |
| Pubmed | A structural basis for interferon-alpha-receptor interactions. | 7.70e-15 | 14 | 108 | 7 | 17517919 | |
| Pubmed | 7.70e-15 | 14 | 108 | 7 | 14983024 | ||
| Pubmed | 7.70e-15 | 14 | 108 | 7 | 25972534 | ||
| Pubmed | 7.70e-15 | 14 | 108 | 7 | 7583919 | ||
| Pubmed | 7.70e-15 | 14 | 108 | 7 | 2987811 | ||
| Pubmed | 7.70e-15 | 14 | 108 | 7 | 21172865 | ||
| Pubmed | Characterization of the murine alpha interferon gene family. | 7.70e-15 | 14 | 108 | 7 | 15254193 | |
| Pubmed | 7.70e-15 | 14 | 108 | 7 | 16278001 | ||
| Pubmed | Recombinant glycoprotein 120 of human immunodeficiency virus is a potent interferon inducer. | 7.70e-15 | 14 | 108 | 7 | 1381203 | |
| Pubmed | 7.70e-15 | 14 | 108 | 7 | 8345204 | ||
| Pubmed | 1.44e-14 | 15 | 108 | 7 | 8786318 | ||
| Pubmed | 1.44e-14 | 15 | 108 | 7 | 15684736 | ||
| Pubmed | 1.44e-14 | 15 | 108 | 7 | 9520456 | ||
| Pubmed | Are CD4 and Fas peptide identities of gp120 relevant to the molecular basis of AIDS pathogenesis? | 1.44e-14 | 15 | 108 | 7 | 17180012 | |
| Pubmed | Role of the Akt pathway in mRNA translation of interferon-stimulated genes. | 1.44e-14 | 15 | 108 | 7 | 18339807 | |
| Pubmed | Interferon induction by HIV-1-infected cells: a possible role of sulfatides or related glycolipids. | 1.44e-14 | 15 | 108 | 7 | 8661419 | |
| Pubmed | Role of retroviral restriction factors in the interferon-α-mediated suppression of HIV-1 in vivo. | 2.55e-14 | 16 | 108 | 7 | 22315404 | |
| Pubmed | Coordinate induction of interferon alpha and gamma by recombinant HIV-1 glycoprotein 120. | 2.55e-14 | 16 | 108 | 7 | 7904170 | |
| Pubmed | Sialoadhesin expressed on IFN-induced monocytes binds HIV-1 and enhances infectivity. | 2.55e-14 | 16 | 108 | 7 | 18414664 | |
| Pubmed | 4.33e-14 | 17 | 108 | 7 | 22814248 | ||
| Pubmed | Characterization of the type I interferon locus and identification of novel genes. | 4.33e-14 | 17 | 108 | 7 | 15233997 | |
| Pubmed | 7.07e-14 | 18 | 108 | 7 | 1905933 | ||
| Pubmed | 1.12e-13 | 19 | 108 | 7 | 7511078 | ||
| Pubmed | 1.12e-13 | 19 | 108 | 7 | 7815507 | ||
| Pubmed | 1.12e-13 | 19 | 108 | 7 | 17360657 | ||
| Pubmed | Translational regulation by HIV leader RNA, TAT, and interferon-inducible enzymes. | 1.12e-13 | 19 | 108 | 7 | 1708818 | |
| Pubmed | 1.12e-13 | 19 | 108 | 7 | 1385305 | ||
| Pubmed | TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B. | 1.71e-13 | 20 | 108 | 7 | 11694501 | |
| Pubmed | 1.71e-13 | 20 | 108 | 7 | 8764000 | ||
| Pubmed | 2.56e-13 | 21 | 108 | 7 | 9108403 | ||
| Pubmed | 3.55e-13 | 11 | 108 | 6 | 18835032 | ||
| Pubmed | High-affinity binding of 125I-labelled mouse interferon to a specific cell surface receptor. | 3.55e-13 | 11 | 108 | 6 | 6444699 | |
| Pubmed | Structural and functional neuropathology in transgenic mice with CNS expression of IFN-alpha. | 3.55e-13 | 11 | 108 | 6 | 10448195 | |
| Pubmed | IFN-alpha can both protect against and promote the development of type 1 diabetes. | 3.55e-13 | 11 | 108 | 6 | 19120292 | |
| Pubmed | Effect of interferon-alpha on immediate early gene expression of murine cytomegalovirus. | 3.55e-13 | 11 | 108 | 6 | 8389790 | |
| Pubmed | The mouse IFN-alpha (Ifa) locus: correlation of physical and linkage maps by in situ hybridization. | 3.55e-13 | 11 | 108 | 6 | 3456887 | |
| Pubmed | Mechanism of SUMOylation-Mediated Regulation of Type I IFN Expression. | 3.55e-13 | 11 | 108 | 6 | 36681180 | |
| Pubmed | Type I interferon dependence of plasmacytoid dendritic cell activation and migration. | 3.55e-13 | 11 | 108 | 6 | 15795237 | |
| Pubmed | 3.55e-13 | 11 | 108 | 6 | 9794439 | ||
| Pubmed | 3.55e-13 | 11 | 108 | 6 | 25310498 | ||
| Pubmed | 3.75e-13 | 22 | 108 | 7 | 7913356 | ||
| Pubmed | 3.75e-13 | 22 | 108 | 7 | 23100517 | ||
| Pubmed | 3.75e-13 | 22 | 108 | 7 | 16160188 | ||
| Pubmed | 5.38e-13 | 23 | 108 | 7 | 9225992 | ||
| Pubmed | Regulation of effector and memory T-cell functions by type I interferon. | 7.09e-13 | 12 | 108 | 6 | 21320124 | |
| Pubmed | MAVS Deficiency Is Associated With a Reduced T Cell Response Upon Secondary RSV Infection in Mice. | 7.09e-13 | 12 | 108 | 6 | 33123150 | |
| Pubmed | A novel anti-viral role for STAT3 in IFN-α signalling responses. | 7.09e-13 | 12 | 108 | 6 | 27988795 | |
| Pubmed | 7.09e-13 | 12 | 108 | 6 | 8656058 | ||
| Pubmed | The physical separation of Lps and Ifa loci in BXH recombinant inbred mice. | 7.09e-13 | 12 | 108 | 6 | 2572648 | |
| Pubmed | Developmental control of IFN-alpha expression in murine embryos. | 7.09e-13 | 12 | 108 | 6 | 7925651 | |
| Pubmed | The role of type 1 interferons in coagulation induced by gram-negative bacteria. | 7.09e-13 | 12 | 108 | 6 | 32016282 | |
| Pubmed | 7.09e-13 | 12 | 108 | 6 | 6188104 | ||
| Pubmed | Ligation of CD180 inhibits IFN-α signaling in a Lyn-PI3K-BTK-dependent manner in B cells. | 7.09e-13 | 12 | 108 | 6 | 26277892 | |
| Pubmed | 7.09e-13 | 12 | 108 | 6 | 6689487 | ||
| Pubmed | Interferon-alpha initiates type 1 diabetes in nonobese diabetic mice. | 7.09e-13 | 12 | 108 | 6 | 18716002 | |
| Pubmed | 7.09e-13 | 12 | 108 | 6 | 30967261 | ||
| Pubmed | 7.09e-13 | 12 | 108 | 6 | 23747509 | ||
| Pubmed | 7.09e-13 | 12 | 108 | 6 | 17434974 | ||
| Interaction | IFNA13 interactions | 2.07e-07 | 11 | 103 | 4 | int:IFNA13 | |
| Interaction | IFNA4 interactions | 2.05e-06 | 41 | 103 | 5 | int:IFNA4 | |
| Interaction | IFNA5 interactions | 4.39e-06 | 22 | 103 | 4 | int:IFNA5 | |
| Interaction | IFNA16 interactions | 4.47e-06 | 7 | 103 | 3 | int:IFNA16 | |
| Interaction | IFNA6 interactions | 7.13e-06 | 8 | 103 | 3 | int:IFNA6 | |
| Interaction | UBR3 interactions | 1.17e-05 | 99 | 103 | 6 | int:UBR3 | |
| Interaction | IFIT1 interactions | 1.90e-05 | 64 | 103 | 5 | int:IFIT1 | |
| Interaction | IFIT3 interactions | 5.61e-05 | 80 | 103 | 5 | int:IFIT3 | |
| Interaction | IFNA14 interactions | 6.92e-05 | 16 | 103 | 3 | int:IFNA14 | |
| Cytoband | 9p22 | 1.52e-13 | 25 | 108 | 7 | 9p22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9p21 | 1.97e-08 | 124 | 108 | 7 | chr9p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq28 | 1.55e-04 | 213 | 108 | 5 | chrXq28 | |
| Cytoband | Xq28 | 8.20e-04 | 176 | 108 | 4 | Xq28 | |
| Cytoband | 19q13.4 | 8.79e-04 | 79 | 108 | 3 | 19q13.4 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q32 | 1.54e-03 | 96 | 108 | 3 | chr13q32 | |
| Cytoband | 20p13 | 1.84e-03 | 102 | 108 | 3 | 20p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr20p13 | 3.12e-03 | 123 | 108 | 3 | chr20p13 | |
| GeneFamily | Interferons | 4.46e-11 | 32 | 74 | 7 | 598 | |
| GeneFamily | Opsin receptors | 8.35e-08 | 11 | 74 | 4 | 215 | |
| GeneFamily | Cyclin dependent kinases | 1.60e-04 | 26 | 74 | 3 | 496 | |
| GeneFamily | Type 1 receptor serine/threonine kinases | 3.42e-04 | 7 | 74 | 2 | 345 | |
| GeneFamily | LIM domain containing | 1.82e-03 | 59 | 74 | 3 | 1218 | |
| GeneFamily | Potassium voltage-gated channel subfamily J | 1.91e-03 | 16 | 74 | 2 | 276 | |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_5 | 2.10e-11 | 29 | 106 | 7 | MM586 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_DN | 6.53e-11 | 85 | 106 | 9 | MM684 | |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_DT_ANTIBODY_CORRELATION_PROFILE_3DY_UP | 1.05e-09 | 27 | 106 | 6 | M40935 | |
| Coexpression | ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NAIVE_NOT_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP | 1.11e-08 | 39 | 106 | 6 | M41095 | |
| Coexpression | GROSS_HYPOXIA_VIA_HIF1A_DN | 6.28e-08 | 131 | 106 | 8 | MM1127 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP | 1.92e-07 | 210 | 106 | 9 | MM751 | |
| Coexpression | ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_RESPONDERS_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP | 2.49e-07 | 34 | 106 | 5 | M41094 | |
| Coexpression | LEE_AGING_NEOCORTEX_DN | 8.94e-07 | 80 | 106 | 6 | MM646 | |
| Coexpression | WORSCHECH_TUMOR_REJECTION_UP | 8.94e-07 | 80 | 106 | 6 | MM1229 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_UP | 1.47e-06 | 87 | 106 | 6 | MM652 | |
| Coexpression | GSE24574_BCL6_LOW_TFH_VS_TCONV_CD4_TCELL_UP | 1.43e-05 | 194 | 106 | 7 | M8340 | |
| Coexpression | GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_DN | 1.64e-05 | 198 | 106 | 7 | M8400 | |
| Coexpression | GSE41867_DAY15_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP | 1.69e-05 | 199 | 106 | 7 | M9523 | |
| Coexpression | GSE3720_LPS_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_UP | 2.49e-05 | 142 | 106 | 6 | M6348 | |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_B | PLA2G7 IPO7 RFX4 IFNA2 IFNA5 IFNA6 IFNA7 IFNA8 IFNA16 IFNA21 KIT | 2.51e-05 | 584 | 106 | 11 | MM1080 |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_POLYSACCHARIDE_ANTIBODY_CORRELATION_PROFILE_3DY_DN | 3.46e-05 | 16 | 106 | 3 | M40964 | |
| Coexpression | LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18_45YO_3DY_DN | 5.94e-05 | 19 | 106 | 3 | M40933 | |
| Coexpression | NABA_SECRETED_FACTORS | 7.09e-05 | 338 | 106 | 8 | MM17064 | |
| Coexpression | NABA_SECRETED_FACTORS | 7.85e-05 | 343 | 106 | 8 | M5883 | |
| Coexpression | GSE21360_NAIVE_VS_SECONDARY_MEMORY_CD8_TCELL_DN | 8.50e-05 | 177 | 106 | 6 | M7632 | |
| Coexpression | GSE7348_LPS_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP | 9.61e-05 | 181 | 106 | 6 | M6849 | |
| Coexpression | PRC2_EED_DN.V1_DN | 1.37e-04 | 193 | 106 | 6 | M2734 | |
| Coexpression | GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_DN | 1.53e-04 | 197 | 106 | 6 | M4294 | |
| Coexpression | GSE27786_LIN_NEG_VS_NKTCELL_UP | 1.66e-04 | 200 | 106 | 6 | M4787 | |
| Coexpression | LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18_45YO_3DY_UP | 2.18e-04 | 29 | 106 | 3 | M41150 | |
| Drug | Hiltonol | 5.69e-08 | 23 | 104 | 5 | CID000431963 | |
| Drug | gunacin | 3.97e-07 | 14 | 104 | 4 | CID000198547 | |
| Drug | tilorone | 5.25e-07 | 35 | 104 | 5 | CID000005475 | |
| Drug | pppA2'-5'A2'-5'A | 5.39e-07 | 15 | 104 | 4 | CID000125229 | |
| Drug | podophyllin | 1.20e-06 | 18 | 104 | 4 | CID011979494 | |
| Drug | Nyco | 1.20e-06 | 18 | 104 | 4 | CID000071618 | |
| Drug | acyclovir | 1.64e-06 | 124 | 104 | 7 | CID000002022 | |
| Drug | HCV-371 | 1.83e-06 | 6 | 104 | 3 | CID003013096 | |
| Drug | AC1L9FQV | 2.08e-06 | 82 | 104 | 6 | CID000444118 | |
| Drug | AC1L18QD | OPN1LW OPN1MW IFNA2 IFNA5 ADCY9 IFNA6 IFNA7 ADRA1D P2RY1 MAPK7 | 2.44e-06 | 325 | 104 | 10 | CID000000213 |
| Drug | formosanin C | 2.82e-06 | 22 | 104 | 4 | CID000073597 | |
| Drug | adefovir dipivoxil | 2.93e-06 | 49 | 104 | 5 | CID000060871 | |
| Drug | 2'-deoxy-3'-thiacytidine | 2.94e-06 | 87 | 104 | 6 | CID000003877 | |
| Drug | linarin | 3.20e-06 | 7 | 104 | 3 | CID005317025 | |
| Drug | Yfrkd | 3.20e-06 | 7 | 104 | 3 | CID000129984 | |
| Drug | Thalidomide [50-35-1]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 3.20e-06 | 195 | 104 | 8 | 5990_UP | |
| Drug | Nitrocaramiphen hydrochloride; Down 200; 10.8uM; HL60; HT_HG-U133A | 3.72e-06 | 199 | 104 | 8 | 3125_DN | |
| Drug | cycloferon | 4.07e-06 | 24 | 104 | 4 | CID000038072 | |
| Drug | hycanthone | 4.83e-06 | 25 | 104 | 4 | CID000003634 | |
| Drug | amantadine | 4.91e-06 | 95 | 104 | 6 | CID000002130 | |
| Drug | 1hiv | 5.10e-06 | 8 | 104 | 3 | CID005479205 | |
| Drug | Chebi:36708 | 5.10e-06 | 8 | 104 | 3 | CID011966289 | |
| Drug | ABMP | 5.68e-06 | 26 | 104 | 4 | CID000080567 | |
| Drug | inosiplex | 6.65e-06 | 27 | 104 | 4 | CID000037510 | |
| Drug | HS 1030 | 7.62e-06 | 9 | 104 | 3 | ctd:C403899 | |
| Drug | iberin | 8.94e-06 | 29 | 104 | 4 | CID000010455 | |
| Drug | penciclovir | 1.03e-05 | 30 | 104 | 4 | CID000004725 | |
| Drug | poly rI:rC | 1.03e-05 | 30 | 104 | 4 | CID011979660 | |
| Drug | AC1L1JM9 | 1.09e-05 | 304 | 104 | 9 | CID000005103 | |
| Drug | pipobroman | 1.09e-05 | 10 | 104 | 3 | CID000004842 | |
| Drug | HS 1183 | 1.09e-05 | 10 | 104 | 3 | ctd:C403900 | |
| Drug | Flavopiridol | 1.09e-05 | 10 | 104 | 3 | DB03496 | |
| Drug | adefovir | 1.11e-05 | 64 | 104 | 5 | CID000060172 | |
| Drug | Cholecalciferol | 1.18e-05 | 233 | 104 | 8 | ctd:D002762 | |
| Drug | AC1L9NBB | 1.27e-05 | 169 | 104 | 7 | CID000449615 | |
| Drug | Azitidin | 1.27e-05 | 169 | 104 | 7 | CID000005726 | |
| Drug | CHEMBL466993 | 1.34e-05 | 32 | 104 | 4 | CID005320808 | |
| Drug | decursinol | 1.49e-05 | 11 | 104 | 3 | CID000442127 | |
| Drug | flesinoxan | 1.49e-05 | 11 | 104 | 3 | CID000057347 | |
| Drug | Destruxin E | 1.49e-05 | 11 | 104 | 3 | CID000107863 | |
| Drug | carprofen | 1.71e-05 | 34 | 104 | 4 | CID000002581 | |
| Drug | tris(2-carboxyethyl)phosphine | 1.98e-05 | 12 | 104 | 3 | ctd:C080938 | |
| Drug | dineolignan | 1.98e-05 | 12 | 104 | 3 | CID005316907 | |
| Drug | HMS3401P14 | 2.07e-05 | 2 | 104 | 2 | CID011743030 | |
| Drug | HMS3401N08 | 2.07e-05 | 2 | 104 | 2 | CID010319097 | |
| Drug | SureCN4359466 | 2.07e-05 | 2 | 104 | 2 | CID010023782 | |
| Drug | HMS3401O14 | 2.07e-05 | 2 | 104 | 2 | CID010479319 | |
| Drug | SureCN4355942 | 2.07e-05 | 2 | 104 | 2 | CID010069391 | |
| Drug | SureCN4352584 | 2.07e-05 | 2 | 104 | 2 | CID010045499 | |
| Drug | SureCN4348158 | 2.07e-05 | 2 | 104 | 2 | CID010251513 | |
| Drug | SureCN4350490 | 2.07e-05 | 2 | 104 | 2 | CID010249602 | |
| Drug | NU6102 | 2.07e-05 | 2 | 104 | 2 | ctd:C466914 | |
| Drug | SureCN4355096 | 2.07e-05 | 2 | 104 | 2 | CID010449125 | |
| Drug | HMS3401E18 | 2.07e-05 | 2 | 104 | 2 | CID009979700 | |
| Drug | SureCN4348425 | 2.07e-05 | 2 | 104 | 2 | CID009999155 | |
| Drug | AC1O6ZEC | 2.07e-05 | 2 | 104 | 2 | CID006539282 | |
| Drug | AC1O6ZEG | 2.07e-05 | 2 | 104 | 2 | CID006539284 | |
| Drug | AC1O6ZEI | 2.07e-05 | 2 | 104 | 2 | CID006539285 | |
| Drug | AC1O6ZE8 | 2.07e-05 | 2 | 104 | 2 | CID006539280 | |
| Drug | AC1O6ZEQ | 2.07e-05 | 2 | 104 | 2 | CID006539289 | |
| Drug | AC1O6ZEW | 2.07e-05 | 2 | 104 | 2 | CID006539292 | |
| Drug | AC1O6ZF2 | 2.07e-05 | 2 | 104 | 2 | CID006539295 | |
| Drug | AC1O6ZF4 | 2.07e-05 | 2 | 104 | 2 | CID006539296 | |
| Drug | CS17 | 2.07e-05 | 2 | 104 | 2 | CID006539297 | |
| Drug | AC1O6ZEU | 2.07e-05 | 2 | 104 | 2 | CID006539291 | |
| Drug | AC1O6ZFS | 2.07e-05 | 2 | 104 | 2 | CID006539308 | |
| Drug | AC1O6ZFU | 2.07e-05 | 2 | 104 | 2 | CID006539309 | |
| Drug | AC1O6ZFC | 2.07e-05 | 2 | 104 | 2 | CID006539300 | |
| Drug | AC1O6ZFE | 2.07e-05 | 2 | 104 | 2 | CID006539301 | |
| Drug | CS19 | 2.07e-05 | 2 | 104 | 2 | CID006539302 | |
| Drug | AC1O6ZFI | 2.07e-05 | 2 | 104 | 2 | CID006539303 | |
| Drug | 18 K | 2.07e-05 | 2 | 104 | 2 | CID006539304 | |
| Drug | AC1O6ZFM | 2.07e-05 | 2 | 104 | 2 | CID006539305 | |
| Drug | AC1O6ZFO | 2.07e-05 | 2 | 104 | 2 | CID006539306 | |
| Drug | AC1O6ZFQ | 2.07e-05 | 2 | 104 | 2 | CID006539307 | |
| Drug | AC1O6ZFW | 2.07e-05 | 2 | 104 | 2 | CID006539310 | |
| Drug | AC1O6ZFY | 2.07e-05 | 2 | 104 | 2 | CID006539311 | |
| Drug | AC1O6ZG0 | 2.07e-05 | 2 | 104 | 2 | CID006539312 | |
| Drug | AC1O6ZG2 | 2.07e-05 | 2 | 104 | 2 | CID006539313 | |
| Drug | AC1O6ZG4 | 2.07e-05 | 2 | 104 | 2 | CID006539314 | |
| Drug | AC1O6ZG6 | 2.07e-05 | 2 | 104 | 2 | CID006539315 | |
| Drug | AC1O6ZG8 | 2.07e-05 | 2 | 104 | 2 | CID006539316 | |
| Drug | SureCN4349169 | 2.07e-05 | 2 | 104 | 2 | CID011975074 | |
| Drug | HMS3401L08 | 2.07e-05 | 2 | 104 | 2 | CID011975075 | |
| Drug | SureCN4354204 | 2.07e-05 | 2 | 104 | 2 | CID011975073 | |
| Drug | SureCN4355632 | 2.07e-05 | 2 | 104 | 2 | CID011975203 | |
| Drug | SureCN4348182 | 2.07e-05 | 2 | 104 | 2 | CID011975205 | |
| Drug | HMS3401F10 | 2.07e-05 | 2 | 104 | 2 | CID011975206 | |
| Drug | SureCN4355780 | 2.07e-05 | 2 | 104 | 2 | CID009843864 | |
| Drug | 2,4-Diamino-5-ketopyrimidine 42 | 2.07e-05 | 2 | 104 | 2 | CID010434333 | |
| Drug | pyran | 2.42e-05 | 37 | 104 | 4 | CID000033703 | |
| Drug | FMAU | 2.42e-05 | 37 | 104 | 4 | CID000072327 | |
| Drug | R 842 | 2.56e-05 | 13 | 104 | 3 | CID000130714 | |
| Drug | anagrelide | 2.69e-05 | 38 | 104 | 4 | CID000002182 | |
| Drug | isofagomine lactam | 2.99e-05 | 39 | 104 | 4 | CID000448980 | |
| Drug | Tolmetin sodium salt dihydrate [64490-92-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 3.20e-05 | 195 | 104 | 7 | 4167_DN | |
| Drug | Lanicemine | 3.25e-05 | 14 | 104 | 3 | CID003038485 | |
| Drug | Lidocaone hydrochloride [73-78-9]; Down 200; 14.8uM; PC3; HG-U133A | 3.30e-05 | 196 | 104 | 7 | 1917_DN | |
| Drug | Estradiol-17 beta [50-28-2]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 3.30e-05 | 196 | 104 | 7 | 5318_UP | |
| Drug | Ethoxyquin [91-53-2]; Down 200; 18.4uM; HL60; HT_HG-U133A | 3.41e-05 | 197 | 104 | 7 | 2559_DN | |
| Disease | blue cone monochromacy (implicated_via_orthology) | 1.29e-10 | 4 | 101 | 4 | DOID:0050679 (implicated_via_orthology) | |
| Disease | Cone monochromatism | 1.16e-05 | 2 | 101 | 2 | cv:C0339537 | |
| Disease | non-functioning pancreatic endocrine tumor (is_marker_for) | 1.16e-05 | 2 | 101 | 2 | DOID:7698 (is_marker_for) | |
| Disease | BORNHOLM EYE DISEASE | 1.16e-05 | 2 | 101 | 2 | C3159311 | |
| Disease | Achromatopsia incomplete, X-linked | 1.16e-05 | 2 | 101 | 2 | C2931753 | |
| Disease | Red-green dyschromatopsia | 1.16e-05 | 2 | 101 | 2 | cv:C0155016 | |
| Disease | Cone monochromatism | 1.16e-05 | 2 | 101 | 2 | C0339537 | |
| Disease | BLUE CONE MONOCHROMACY | 1.16e-05 | 2 | 101 | 2 | 303700 | |
| Disease | blue cone monochromacy (is_implicated_in) | 1.16e-05 | 2 | 101 | 2 | DOID:0050679 (is_implicated_in) | |
| Disease | Medullary Neoplasms | 6.93e-05 | 4 | 101 | 2 | C0751887 | |
| Disease | Brain Stem Neoplasms, Primary | 6.93e-05 | 4 | 101 | 2 | C0751886 | |
| Disease | Pontine Tumors | 6.93e-05 | 4 | 101 | 2 | C0751889 | |
| Disease | Mesencephalic Neoplasms | 6.93e-05 | 4 | 101 | 2 | C0751888 | |
| Disease | Brain Stem Neoplasms | 6.93e-05 | 4 | 101 | 2 | C0677866 | |
| Disease | liposarcoma | 1.72e-04 | 6 | 101 | 2 | C0023827 | |
| Disease | cholesteryl ester 24:4 measurement | 2.41e-04 | 7 | 101 | 2 | EFO_0021447 | |
| Disease | Leukemia, Myelocytic, Acute | 3.29e-04 | 173 | 101 | 5 | C0023467 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 4.04e-04 | 181 | 101 | 5 | DOID:684 (is_implicated_in) | |
| Disease | Acute Promyelocytic Leukemia | 5.31e-04 | 46 | 101 | 3 | C0023487 | |
| Disease | argininosuccinate measurement | 6.25e-04 | 11 | 101 | 2 | EFO_0010461 | |
| Disease | Medulloblastoma | 6.79e-04 | 50 | 101 | 3 | C0025149 | |
| Disease | Squamous cell carcinoma of the head and neck | 7.62e-04 | 52 | 101 | 3 | C1168401 | |
| Disease | Malignant Neoplasms | 9.97e-04 | 128 | 101 | 4 | C0006826 | |
| Disease | diacylglycerol 38:4 measurement | 1.03e-03 | 14 | 101 | 2 | EFO_0020066 | |
| Disease | Malignant neoplasm of skin | 1.10e-03 | 59 | 101 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 1.10e-03 | 59 | 101 | 3 | C0037286 | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 1.18e-03 | 15 | 101 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | pancreatic adenocarcinoma (is_implicated_in) | 1.18e-03 | 15 | 101 | 2 | DOID:4074 (is_implicated_in) | |
| Disease | Hypertriglyceridemia | 1.18e-03 | 15 | 101 | 2 | C0020557 | |
| Disease | osteoarthritis (implicated_via_orthology) | 1.18e-03 | 15 | 101 | 2 | DOID:8398 (implicated_via_orthology) | |
| Disease | pancreatic ductal carcinoma (is_implicated_in) | 1.35e-03 | 16 | 101 | 2 | DOID:3587 (is_implicated_in) | |
| Disease | Acute myeloid leukemia | 1.53e-03 | 17 | 101 | 2 | cv:C0023467 | |
| Disease | LEUKEMIA, ACUTE MYELOID | 1.53e-03 | 17 | 101 | 2 | 601626 | |
| Disease | melanoma | 1.66e-03 | 248 | 101 | 5 | C0025202 | |
| Disease | body surface area | 1.67e-03 | 643 | 101 | 8 | EFO_0022196 | |
| Disease | acute pancreatitis | 1.71e-03 | 18 | 101 | 2 | EFO_1000652 | |
| Disease | sweet liking measurement | 1.71e-03 | 18 | 101 | 2 | EFO_0010156 | |
| Disease | caudal middle frontal gyrus volume measurement | 1.71e-03 | 18 | 101 | 2 | EFO_0010290 | |
| Disease | level of Sterol ester (27:1/20:3) in blood serum | 1.91e-03 | 19 | 101 | 2 | OBA_2045199 | |
| Disease | diacylglycerol 38:3 measurement | 1.91e-03 | 19 | 101 | 2 | EFO_0020065 | |
| Disease | Osteoarthritis of hip | 2.12e-03 | 20 | 101 | 2 | C0029410 | |
| Disease | level of Phosphatidylinositol (18:0_18:2) in blood serum | 2.33e-03 | 21 | 101 | 2 | OBA_2045156 | |
| Disease | Hodgkin Disease | 2.56e-03 | 22 | 101 | 2 | C0019829 | |
| Disease | level of Phosphatidylinositol (18:0_20:4) in blood serum | 2.80e-03 | 23 | 101 | 2 | OBA_2045158 | |
| Disease | airway responsiveness measurement | 3.05e-03 | 24 | 101 | 2 | EFO_0006897 | |
| Disease | stearoylcarnitine measurement | 3.05e-03 | 24 | 101 | 2 | EFO_0021045 | |
| Disease | nephrotic syndrome (biomarker_via_orthology) | 3.05e-03 | 24 | 101 | 2 | DOID:1184 (biomarker_via_orthology) | |
| Disease | alpha-linolenic acid measurement | 3.31e-03 | 25 | 101 | 2 | EFO_0007759 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CFDSFLAMWDVSDIR | 326 | Q9NVA4 | |
| SSFGFVRRWNCILMR | 246 | P51689 | |
| RLWCVLGAALEMFAS | 706 | Q8WWN8 | |
| EDILWCTEMERVFGF | 856 | Q9Y6K1 | |
| SGDVWEVLILMDFCR | 116 | Q2M2I8 | |
| LRWCFEGLMKIQFSR | 596 | Q9H221 | |
| DLWSVGCIFAEMFRR | 201 | Q00534 | |
| LFCRSEEVRPAGMVW | 1296 | O75129 | |
| VFFWRRDTGQCMASL | 1256 | Q9ULI1 | |
| ERAEFERLWVAFSGC | 71 | Q6ZS82 | |
| RCHWSDMFTGRLRTE | 81 | P46060 | |
| RWMVVCKPFGNVRFD | 151 | P04000 | |
| RWMVVCKPFGNVRFD | 151 | P0DN78 | |
| QFLLMWSCFGTRVIR | 426 | Q33E94 | |
| RWMVVCKPFGNVRFD | 151 | P0DN77 | |
| GRLCRDWDQMFAFAQ | 251 | O15528 | |
| WSVGCIFGEMLARRQ | 246 | Q13164 | |
| DWIFGDAMCKLQRFI | 116 | P47900 | |
| RYLADMFTTCVDIRW | 66 | Q14500 | |
| EDFAAFRAWLRCYGM | 251 | Q96FI4 | |
| MRGARGAWDFLCVLL | 1 | P10721 | |
| LGVRNMWRCSFDRGD | 391 | Q96JK4 | |
| MRGFWARLSLTVCGD | 401 | Q8N158 | |
| RDFVAEFLFWASLCM | 236 | P04424 | |
| VSFDFSCLEMVRELW | 51 | Q5T1J6 | |
| DWRIAMTCERVFLIS | 176 | Q92952 | |
| PCAWEVVRAEIMRSF | 161 | P01568 | |
| EQPRLEFLMRKCGWF | 121 | Q7Z6M2 | |
| EFLMRKCGWFVRELR | 126 | Q7Z6M2 | |
| SLEMERRDKGFCSWF | 96 | Q9P1W3 | |
| VCIGFTRAFRMVWQN | 476 | Q63HM2 | |
| SSELGYMRARACWVL | 466 | O95373 | |
| PCAWEVVRAEIMRSF | 161 | P01569 | |
| PCAWEVVRAEIMRSF | 161 | P01567 | |
| MAFFDSLVRREIEGW | 416 | Q96JK2 | |
| MKWLFEEFAIDGRFC | 1116 | P54098 | |
| DLRASERFLHFMLGW | 616 | P09848 | |
| FRMRFYVAWIAAECG | 241 | Q96N66 | |
| VARGFLAAFDAAWMV | 406 | Q8TDZ2 | |
| GRRWCTDVFERFVAA | 566 | Q96MM6 | |
| FKREWSSVMRCVAVF | 101 | Q9Y5U4 | |
| LFGTMVEEVRWRECV | 426 | Q495T6 | |
| FDFRGMRLDWFRLQA | 481 | Q9Y2A7 | |
| DQRFRCGIALDAWMF | 286 | Q13093 | |
| RWMVVCKPFGNVRFD | 151 | P04001 | |
| GENWIFGDFMCKFIR | 96 | Q96P68 | |
| RWFAVRLDAICAMFV | 946 | O15439 | |
| RVVMFRFEFWDCGES | 106 | Q9BU20 | |
| DMWSVGCIFAEMFRR | 196 | P11802 | |
| DTFFRMHWNCGRIIL | 336 | Q9NQT6 | |
| YSFGLIIWEMARRCI | 431 | P36894 | |
| LCGILGMRRFKFDVW | 496 | O60503 | |
| RADMWSCGVILFALL | 211 | Q8TDC3 | |
| AAFAAWLRGCLRMVL | 446 | Q92839 | |
| CAWEVVRAEIMRSFS | 161 | P01563 | |
| SCAWEVVRAEIMRSF | 161 | P32881 | |
| AMCAWDARIRYALGE | 96 | Q18PE1 | |
| IWSLGCIFAEMVTRR | 186 | P24941 | |
| ELAFVCRMDTWDPRI | 1201 | Q9BYK8 | |
| EEIEFWRNRCMDLSG | 276 | Q9P225 | |
| AEVLCRGRDFVMWKF | 346 | Q9NVU0 | |
| RGEGVFMASRCFWDA | 101 | Q8WW35 | |
| CGFDSMDSALEWLRR | 71 | Q9BTA0 | |
| CARGFLAAFDTAWMV | 411 | O94851 | |
| PCAWEVVRAEIMRSF | 161 | P05013 | |
| FRVSMDGEWLCLREL | 31 | Q7L099 | |
| RYLADMFTTCVDIRW | 66 | B7U540 | |
| MAARTAFGAVCRRLW | 1 | P82664 | |
| WMFCGKRFTRSDELQ | 681 | Q02446 | |
| VEEAMYRSIRWLDRC | 171 | Q9BXR0 | |
| ISACARWFMGEILAS | 246 | Q6P5X7 | |
| RRARIWFPMFSFFEC | 376 | Q96LT4 | |
| EWRSRAAKFEEMCGL | 606 | O60502 | |
| VWDLRTGRCIMFLEG | 391 | O43172 | |
| PCAWEVVRAEIMRSF | 161 | P05015 | |
| YAMGFDWRIGDALCR | 91 | P32249 | |
| RRTARMVAEWQCVGF | 316 | Q9BVL4 | |
| CVVVAWVYGADRFMD | 491 | P48029 | |
| GFVAETTEELCRRWM | 636 | P14410 | |
| TTEELCRRWMQLGAF | 641 | P14410 | |
| RAVDRARAWCEMVGI | 741 | O60733 | |
| ARAWCEMVGIQYFRL | 746 | O60733 | |
| LGRSVMQDFWRRSCL | 316 | A6NNN8 | |
| AMIDIFCSAEFRDWN | 546 | Q9NRC1 | |
| IYAMGLVFWEIARRC | 401 | P36897 | |
| CWLNAFAEMLRFGDR | 361 | O75908 | |
| ELWRNMKFGTIFCGR | 31 | Q16533 | |
| MFLVFERCQDGWFKG | 471 | Q7Z6J0 | |
| MEVLGFWAFGRAFCD | 156 | P25100 | |
| LCDMDVFDAYLPWRR | 101 | Q9GZX3 | |
| LARGDVCTARWMFET | 471 | A4UGR9 | |
| LRLGSWNVIMFVCFE | 276 | P25874 | |
| RRDCMWSGFSARERL | 91 | P12524 | |
| WKILFAECGRGVSMF | 461 | Q0IIM8 | |
| GAEYVSAREWMRICF | 1046 | O75533 | |
| SAREWMRICFELLEL | 1051 | O75533 | |
| FFCSMSGRAWVSREE | 276 | A6NNV3 | |
| FFCSMSGRAWVSREE | 316 | P0DV79 | |
| MALRSRFWGLFSVCR | 1 | Q9H0U6 | |
| WDMFFCEGVKIIFRV | 541 | Q4KMP7 | |
| WLAQFMDGARREIVC | 281 | Q99835 | |
| FPREWCMAERIAVEF | 306 | Q5VIR6 | |
| RRAFADMRWNCSSIE | 81 | O96014 | |
| VACFMRLSWAAAAGR | 1331 | Q9UPU5 | |
| AECYTVGELWDRAFM | 176 | Q7Z7G8 | |
| FLRGARAMCIESWAR | 431 | Q8TEQ8 | |
| RAMCIESWARFSLVR | 436 | Q8TEQ8 | |
| RGSCWETAVGIEFMR | 571 | Q8TDI7 | |
| SSVLRVWDMFFCEGV | 286 | Q9BXI6 | |
| VWDMFFCEGVKIIFR | 291 | Q9BXI6 | |
| ECSRGFFWRNAMRAH | 446 | Q6IV72 | |
| RFWCPRLAAFMERAG | 356 | Q9H091 | |
| TFDVAMRFLYECPWR | 611 | P11498 | |
| IRGDRCWRDLTCMDF | 226 | Q96S06 |